DNA Q3 2023 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$55M-16.5% YoY

Gross Profit

$49M87.5% margin

Operating Income

-$286M-516.7% margin

Net Income

-$303M-546.4% margin

EPS (Diluted)

$-6.21

QoQ Revenue Growth

-31.2%

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$78M

Stock-Based Comp.

$53M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$774M

Stockholders' Equity

$1.3B

Cash & Equivalents

$1.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$55M	$66M	-16.5%
Gross Profit	$49M	$42M	+16.2%
Operating Income	-$286M	-$655M	+56.3%
Net Income	-$303M	-$670M	+54.8%

Revenue Segments

Service

$12M64%

Product

$6M36%